Literature DB >> 6824125

Characteristics of chloroquine binding to glass and plastic.

T G Geary, M A Akood, J B Jensen.   

Abstract

Chloroquine, a 4-aminoquinoline derivative that can be radically curative in the therapy of malaria due to Plasmodium falciparum, binds to glass to an extent which can seriously decrease the availability of the drug. Preparations of chloroquine in various solutions showed decreases in concentration of up to 40% in glass containers. Passage of solutions of chloroquine over columns of glass beads or glass wool decreased chloroquine concentrations by up to 70%. Chloroquine was found to bind extensively to cellulose acetate filters, but showed little binding to polycarbonate filters or to plastics of various types, including polycarbonate, polypropylene, and polystyrene. Human serum at concentrations from 5-50% inhibited the binding of chloroquine to glass. Equilibrium dialysis experiments indicated that human serum possesses a large number of binding sites for the drug; it is also possible that factors in the serum compete for drug-binding sites on glass. It is imperative for laboratory workers, especially those in the field, to recognize the significant reductions in chloroquine concentration which occur when the drug is prepared or stored in glass containers. Such reductions can alter the interpretation of chloroquine sensitivity studies and may lead to inaccurate reports of chloroquine resistance.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6824125     DOI: 10.4269/ajtmh.1983.32.19

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  11 in total

1.  Protective cardiovascular effects of diazepam in experimental acute chloroquine poisoning.

Authors:  B Riou; A Rimailho; M Galliot; R Bourdon; Y Huet
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

Review 2.  Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements.

Authors:  J Ducharme; R Farinotti
Journal:  Clin Pharmacokinet       Date:  1996-10       Impact factor: 6.447

3.  Interpretation of chloroquine pharmacokinetic data.

Authors:  A McLachlan; S Tett; R Day; D Cutler
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 4.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

5.  Diazepam does not improve the mechanical performance of rat cardiac papillary muscle exposed to chloroquine in vitro.

Authors:  B Riou; Y Lecarpentier; P Barriot; P Viars
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

Review 6.  Clinical pharmacokinetics of antimalarial drugs.

Authors:  N J White
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

7.  A dose-ranging study of the pharmacokinetics of hydroxy-chloroquine following intravenous administration to healthy volunteers.

Authors:  S E Tett; D J Cutler; R O Day; K F Brown
Journal:  Br J Clin Pharmacol       Date:  1988-09       Impact factor: 4.335

8.  Plasma protein binding of the enantiomers of hydroxychloroquine and metabolites.

Authors:  A J McLachlan; D J Cutler; S E Tett
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

9.  Susceptibility of human malaria parasites to chloroquine is pH dependent.

Authors:  A Yayon; Z I Cabantchik; H Ginsburg
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

10.  Self-reported data: a major tool to assess compliance with anti-malarial combination therapy among children in Senegal.

Authors:  Aurélia Souares; Patricia Moulin; Sophie Sarrassat; Marie-Paule Carlotti; Richard Lalou; Jean-Yves Le Hesran
Journal:  Malar J       Date:  2009-11-17       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.